๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer

โœ Scribed by Kimura, Hideki; Yamaguchi, Yutaka

Book ID
122404932
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
824 KB
Volume
13
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A Phase III randomized study of interleu
A Phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma
โœ Hideki Kimura; Yutaka Yamaguchi ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 141 KB ๐Ÿ‘ 2 views

## Background: Adoptive immunotherapy with interleukin-2 (il-2) and lymphokine-activated killer (lak) cells has resulted in response among some patients with advanced malignant disease. however, the relative therapeutic benefit of adoptive immunotherapy as an adjuvant to surgery has not been determ

The requirements for successful immunoth
The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells
โœ Reyer T. Ottow; Alexander M. M. Eggermont; E. Philip Steller; Paul H. Sugarbaker ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 907 KB

In a significant proportion of patients with gastrointestinal and ovarian malignancy the peritoneal cavity is a prominent site at which surgical treatment fails. Adjuvant treatments directed at this site should be investigated in an attempt to improve survival in patients with these cancers. In the